Protara Therapeutics, Inc.

Healthcare

NASDAQ:TARA · NASDAQ Global Market

Market Cap $157.06M Beta 1.45 P/E (TTM) -2.7

$3.98 -1.27%

-$0.05 today

52W Low $2.77High $7.82

Vol 0.80M · Avg 0.73M

EPS (TTM) -$1.48Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+38.19%

Period High

$7.56

Period Low

$2.78

Latest

$3.98

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

SELLAS Life Sciences Group, Inc.

NASDAQ:SLS

$1.18B

Genfit S.A.

GNFT

$445.68M

Prelude Therapeutics Incorporated

NASDAQ:PRLD

$330.29M

OmniAb, Inc.

NASDAQ:OABI

$259.02M

Orchestra BioMed Holdings, Inc.

NASDAQ:OBIO

$234.52M

Codexis, Inc.

NASDAQ:CDXS

$226.33M

MediWound Ltd.

NASDAQ:MDWD

$153.32M

Invivyd, Inc.

NASDAQ:IVVD

$128.55M

Neonc Technologies Holdings, Inc.

NASDAQ:NTHI

$99.38M

Sangamo Therapeutics, Inc.

NASDAQ:SGMO

$70.88M

What is the latest TARA filing?

The latest filing shown is 4 dated Jun 16, 2026.

How many recent filings does TARA have?

Intrinsic Alpha currently shows 20 recent filings for TARA.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.